Healthcare IT News November 25, 2024
Adam Ang

A pilot validation study found that the AI helped hasten case reviews and data analysis and determine the necessity of antibiotic use.

Singapore General Hospital is developing an AI solution to determine the necessity of prescribing antibiotics, reduce their use, and identify the most appropriate ones for each patient.

Developed with DXC Technology, the Augmented Intelligence in Infectious Diseases (AI2D) is an AI model currently covering pneumonia cases. It was built using deidentified clinical data, including X-rays, clinical symptoms, vital signs, and infection response trends, of around 8,000 SGH patients between 2019 and 2020. It covered seven broad-spectrum intravenous antibiotics commonly prescribed against pneumonia.

FINDINGS

Last year, the research team led by the SGH Pharmacy division, conducted a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Health System / Hospital, Provider, Survey / Study, Technology, Trends
Joint Commission revises workplace violence criteria
10 headwinds for health systems in 2025
Trinity, Cleveland Clinic and more: 11 systems back in the black
Where 74 health system leaders are focused to prepare for 2025
How a $1B City of Hope project came to 'light'

Share This Article